Hinge Health, Inc. (HNGE)
2025-06-30 | ||||
---|---|---|---|---|
Revenue | 139,098 | |||
Cost of revenue | 41,335 | |||
Gross profit | 97,763 | |||
Sales and marketing | 147,228 | |||
Research and development | 279,962 | |||
General and administrative | 251,244 | |||
Total operating expenses | 678,434 | |||
Loss from operations | -580,671 | |||
Other income, net | 4,694 | |||
Net loss before income taxes | -575,977 | |||
Provision (benefit) for income taxes | -326 | |||
Net loss | -575,651 | |||
Adjustment to reflect deemed contribution from series d and series e redeemable convertible preferred stock extinguishment | - | |||
Net loss attributable to common stockholders | -575,651 | |||
Earnings per share, basic | -13.1 | |||
Earnings per share, diluted | -13.1 | |||
Weighted average number of shares outstanding, basic | 43,931,000 | |||
Weighted average number of shares outstanding, diluted | 43,931,000 |